Latest News

MS Voice Newsletter – October 2023

October 31, 2023 | Advocacy, Awards, Carer, Carers, Education, Funding, Grants, MS Voice, Newsletter, Petition, Scholarships, Training

Welcome to our October 2023 edition of MS Voice. Spring has sprung…….although it seems we are flip flopping between seasons at the moment with this changeable weather! For today, however, you can spring into the October edition of MS Voice, […]


Major announcement: Pharmac Initiates Consultation to fund Ocrelizumab for Primary Progressive MS.

June 22, 2023 | Advocacy, Funding, Media, Progressive

Multiple Sclerosis New Zealand (MSNZ) is delighted to share that Pharmac have commenced consultation to fund Ocrelizumab for Primary Progressive MS. Currently, those with PPMS have no access to any disease modifying therapies. Ocrelizumab has been proven in trials to […]


Update: Siponimod (Mayzent) for Secondary Progressive MS

November 16, 2022 | Advocacy, Funding, Treatments

At the August 2022 meeting of PHARMAC’s Pharmacology and Therapeutics Advisory Committee (PTAC), Multiple Sclerosis NZ (MSNZ) made a submission in support of the funding of Siponimod (Mayzent) for Secondary Progressive MS. At this meeting PTAC recommended listing with low priority and have requested further advice from the […]


Katy’s Southern Alps climb

August 8, 2022 | Funding, Grants, Life with MS, Scholarships

Last year I was the successful recipient of the Mastering Mountains Grant for people with FND and MS. My objective was to climb a 3,000m peak the Southern Alps. When I first submitted my application for the Grant I had […]


Funding opportunity

May 10, 2022 | Funding, Research, Study, Training

MSNZ is delighted with the announcement from the New Zealand MS Research Trust that they have received funding of NZ$150,000 a year for three years to support neurologists who wish to travel overseas to specialise in the treatment of people […]